Do you want to read an article? Please log in or register.
Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study
Further Publications
COMMENTED
Related content
COMMENTED
Blindness and Vision Impairment
Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control
Ophthalmology.
Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP
doi: 10.1016/j.
Lenses
Studies using concentric ring bifocal and peripheral add multifocal contact lenses to slow myopia progression in school-aged children: a meta-analysis.
Ophthalmic Physiol Opt.
Li SM, Kang MT, Wu SS, Meng B, Sun YY, Wei SF, Liu L, Peng X, Chen Z, Zhang F, Wang N
doi: 10.1111/opo.12332.
Lenses
Effect of Orthokeratology on myopia progression: twelve-year results of a retrospective cohort study
BMC Ophthalmol.
Lee YC, Wang JH, Chiu CJ
doi: 10.1186/s12886-017-0639-4.
Blindness and Vision Impairment
Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis
JAMA Ophthalmol.
Gong Q, Janowski M, Luo M, Wei H, Chen B, Yang G, Liu L
doi: 10.1001/
Macular Diseases
The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20
Ophthalmology.
Keenan TD, Wiley HE, Agrón E, Aronow ME, Christen WG, Clemons TE, Chew EY, Age-Related Eye Disease Study and Age-Related Eye Disease Study 2 Research Groups.
doi: 10.1016/j.ophtha.2019.06.023.
RECOMMENDED
Lenses
Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial
★ 2
Recommended by
Dr Katarzyna Konieczka, Faculty Member
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
JAMA.
Walline JJ, Walker MK, Mutti DO, Jones-Jordan LA, Sinnott LT, Giannoni AG, Bickle KM, Schulle KL, Nixon A, Pierce GE, Berntsen DA, BLINK Study Group
doi: 10.1001/jama.2020.10834.
COMMENTED
Macular Diseases
Incidence and Progression of Nongeographic Atrophy in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Clinical Trial
★ 2
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
doi: 10.1001/jamaophthalmol.2020.0437.
Macular Diseases
A systematic review on the quality, validity and usefulness of current cost-effectiveness studies for treatments of neovascular age-related macular degeneration
Acta Ophthalmol.
Elshout M, Webers CAB, van der Reis MI, Schouten JSAG
doi: 10.1111/aos.13824.
COMMENTED
Macular Diseases
A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION
Retina.
Markowitz SN, Devenyi RG, Munk MR, Croissant CL, Tedford SE, Rückert R, Walker MG, Patino BE, Chen L, Nido M, Tedford CE
doi: 10.1097/IAE.0000000000002632.